Protective peptides that are orally active and mechanistically nonchiral

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 3, 2004, Pages 1190-1197

  Brenneman, Douglas E ^a,c   Spong, Catherine Y ^a   Hauser, Janet M ^a   Abebe, Daniel ^a   Pinhasov, Albert ^b   Golian, Tania ^b   Gozes, Illana ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMYLOID BETA PROTEIN[25-35]; APOLIPOPROTEIN E; ASPARAGINYLALANYLPROLYLVALYLSERYLISOLEUCYLPROLYLGLUTAMINE; DEXTRO AMINO ACID; N METHYL DEXTRO ASPARTIC ACID; PEPTIDE; SERYLALANYLLEUCYLLEUCYLARGINYLSERYLISOLEUCYLPROLYLALANINE; TETRODOTOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; EMBRYO; FETAL ALCOHOL SYNDROME; FETUS DEATH; KNOCKOUT MOUSE; LEARNING DISORDER; MAZE TEST; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL;

ADMINISTRATION, ORAL; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ETHANOL; FEMALE; FETAL ALCOHOL SYNDROME; MICE; MICE, KNOCKOUT; NEURONS; NEUROPROTECTIVE AGENTS; OLIGOPEPTIDES; PEPTIDES; PREGNANCY; RATS;

EID: 2442681629     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.063891     Document Type: Article

References (38)

1. Arispe N, Pollard HB, and Rojas E (1993) Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [AβP-(1-40)] in bilayer membranes. Proc Natl Acad Sci USA 90:10573-10577.
2. Ashur-Fabian O, Giladi E, Furman S, Steingart RA, Wollman Y, Fridkin M, Brenneman DE, and Gozes I (2001) Vasoactive intestinal peptide and related molecules induce nitrite accumulation in the extracellular milieu of rat cerebral cortical cultures. Neurosci Lett 307:167-170.
3. Ashur-Fabian O, Segal-Ruder Y, Skutelsky E, Brenneman DE, Steingart R, Giladi E, and Gozes I (2003) The neuroprotective peptide NAPVSIPQ inhibits the aggregation of the beta-amyloid. Peptides 24:1413-1423.
4. Bassan M, Zamostiano R, Davidson A, Pinhasov A, Giladi E, Perl O, Bassan H, Blat C, Gibney G, Glazner G, et al. (1999) Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J Neurochem 72:1283-1293.
5. Beni-Adani L, Gozes I, Cohen Y, Assaf Y, Steingart RA, Brenneman DE, Eizenberg O, Trembolver V, and Shohami E (2001) A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J Pharmacol Exp Ther 296:57-63.
6. Bhattacharyya J and Sharma KK (2001) Conformational specificity of mini-alphaA-crystallin as a molecular chaperone. J Pept Res 57:428-434.
7. Bischofberger P, Han W, Feifel B, Schonfeld HJ, and Christen P (2003) D-peptides as inhibitors of the DnaK/DnaJ/GrpE chaperone System. J Biol Chem 278:19044-19047.
8. Brenneman DE and Eiden LE (1986) Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc Natl Acad Sci USA 83:1159-1162.
9. Brenneman DE and Gozes I (1996) A femtomolar-acting neuroprotective peptide. J Clin Investig 97:2299-2307.
10. Brenneman DE, Hauser J, Neale E, Rubinraut S, Fridkin M, Davidson A, and Gozes I (1998) Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides. J Pharmacol Exp Ther 285:619-627.
11. Brenneman DE, Neale EA, Habig WH, Bowers LM, and Nelson PG (1983) Developmental and neurochemical specificity of neuronal deficits produced by electrical impulse blockade in dissociated spinal cord cultures. Dev Brain Res 9:13-27.
12. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, and Pericak-Vance MA (1993) Gene dose of apolipoprotein-E type-4 allele and the risk of Alzheimer's disease in late onset families. Science (Wash DC) 261:921-923.
13. Cribbs DH, Pike CJ, Weinstein SL, Velazquez P, and Cotman CW (1997) All-D-enantiomers of beta-amyloid exhibit similar biological properties to all-L-beta-amyloid. J Biol Chem 272:7431-7436.
14. Glazner GW, Boland A, Brenneman DE, Gozes I, and Mattson MP (1998) ADNF-9 protects neurons against oxidative stress-induced death by activation of the transcription factor NF-kappa B. Mol Biol Cell 9:2049.
15. Glazner GW and Mattson MP (2000) Differential effects of BDNF, ADNF9 and TNFα on levels of NMDA receptor subunits, calcium homeostasis and neuronal vulnerability to excitotoxicity. Exp Neurol 161:442-452.
16. Gordon I, Grauer E, Genis I, Sehayek E, and Michaelson DM (1995) Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci Lett 199:1-4.
17. Gozes I, Alcalay R, Giladi E, Pinhasov A, Furman S, and Brenneman DE (2002) NAPVSIPQ accelerates the performance of normal rats in the water maze. J Mol Neurosci 19:167-170.
18. Gozes I, Bachar M, Bardea A, Davidson A, Rubinraut S, Fridkin M, and Giladi E (1997) Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implications for early treatment of Alzheimer's disease. J Neurobiol 33:329-342.
19. Gozes I and Brenneman DE (1996) Activity-dependent neurotrophic factor (ADNF). An extracellular neuroprotective chaperonin. J Mol Neurosci 7:235-244.
20. Gozes I and Brenneman DE (2000) A new concept in the pharmacology of neuroprotection. J Mol Neurosci 14:61-68.
21. Gozes I, Giladi E, Pinhasov A, Bardea A, and Brenneman DE (2000) Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improves performance in a water maze. J Pharmacol Exp Ther 293:1091-1098.
22. Gressens P, Hill JM, Gozes I, Fridkin M, and Brenneman DE (1993) Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature (Lond) 362:155-158.
23. Gressens P, Marret S, Bodenant C, Schwendimann L, and Evrard P (1999) Activity-dependent neurotrophic factor-14 requires protein kinase C and mitogen-associated protein kinase kinase activation to protect the developing mouse brain against excitatoxicity. J Mol Neurosci 13:199-210.
24. Hill JM, Mervis RF, Avidor R, Moody TW, and Brenneman DE (1993) HIV envelope protein-induced neuronal damage and retardation of behavioral-development in rat neonates. Brain Res 603:222-233.
25. Ignatius MJ, Gebicke-Harter PJ, Skene JH, Schilling JW, Weisgraber KH, Mahley RW, and Shooter EM (1986) Expression on apolipoprotein E during nerve degeneration and regeneration. Proc Nat Acad Sci USA 83:1125-1129.
26. Leker RR, Teichner A, Grigoriadis N, Ovadia H, Brenneman DE, Fridkin M, Giladi E, Romano J, and Gozes I (2002) NAPVSIPQ, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death. Stroke 33:1085-1092.
27. Offen D, Sherki Y, Melamed E, Fridkin M, Brenneman DE, and Gozes I (2000) Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease. Brain Res 854:257-262.
28. Romijn HJ, Habets AM, Mud MT, and Wolters PS (1982) Nerve outgrowth, synaptogenesis and bioelectric activity in rat cerebral cortex tissue cultured in serum-free chemically defined medium. Dev Brain Res 2:140-146.
29. Schmechel D, Marangos PJ, and Brightman J (1978) Neuron specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature (Lond) 276:834-836.
30. Spong CY, Abebe DT, Gozes I, Brenneman DE, and Hill JM (2001) Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J Pharmacol Exp Ther 297:774-779.
31. Steingart RA, Solomon B, Brenneman DE, Fridkin M, and Gozes I (2000) VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress. J Mol Neurosci 15:137-145.
32. Wade D, Boman A, Wahlin B, Drain CM, Andreu D, Boman HG, and Merrifield RB (1990) All D-amino acid-containing channel-forming antibiotic peptides. Proc Natl Acad Sci USA 87:4761-4765.
33. Webster WS, Walsh DA, Lipson AH, and McEwen SE (1980) Teratogenesis after acute alcohol exposure in inbred and outbred mice. Neurobehav Toxicol 2:227-234.
34. White DM, Walker S, Brenneman DE, and Gozes I (2000) CREB contributes to the increased neurite outgrowth of sensory neurons induced by vasoactive intestinal polypeptide and activity-dependent neurotrophic factor. Brain Res 868:31-38.
35. Wilkemeyer MF, Chen SY, Menkari CE, Brenneman DE, Sulik KK, and Charness ME (2003) Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity. Proc Natl Acad Sci USA 100:8543-8548.
36. Wilkemeyer MF, Menkari CE, Spong CY, and Charness ME (2002) Peptide antagonists of ethanol inhibition of L1-mediated cell-cell adhesion. J Pharmacol Exp Ther 303:110-116.
37. Zemlyak I, Furman S, Brenneman DE, and Gozes I (2000) A novel peptide prevents death in enriched neuronal cultures. Regul Pept 96:39-43.
38. Zhou NM, Luo ZW, Luo JS, Fan XJ, Cayabyab M, Hiraoka M, Liu DX, Han XB, Pesavento J, Dong CZ, et al. (2002) Exploring the stereochemistry of CXCR4-peptide recognition and inhibiting HIV-1 entry with D-peptides derived from chemokines. J Biol Chem 277:17476-17485.